← Back
$REPL All transactions

Replimune Group, Inc.

▼ SELL 10b5-1 Plan

$ Value

$52K

Shares

6,500

Price

$8

Filed

Apr 6

Insider

Name

Sarchi Christopher

Title

Chief Commercial Officer

CIK

0001986597

Roles

Officer

Transaction Details

Transaction Date

2026-04-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

151,588

Footnotes

The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 15, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.06. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Following the sales reported on this Form 4, the reporting person continues to beneficially own 151,588 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 250,425 shares of the Issuer's common stock, 142,555 of which are exercisable as of the date hereof.

Filing Info

Accession No.

0001104659-26-039967

Form Type

4

Issuer CIK

0001737953

Sarchi Christopher's History

Date Ticker Type Value
2026-04-02 REPL $52K
2026-04-01 REPL A $0
2026-04-01 REPL A $0
2025-05-20 REPL $30K

Other Insiders at REPL (90d)

Insider Bought Sold Last
SLATTERY JOSEPH P 2026-04-01
BAKER BROS. ADVISORS LP 2026-04-01
Astley-Sparke Philip 2026-04-01
Pucci Paolo 2026-04-01
Dhingra Kapil 2026-04-01
Balachandran Madhavan 2026-04-01
Weinand Dieter 2026-04-01
Hill Emily Luisa
Chief Financial Officer
2026-04-01
Oliger Christy J. 2026-04-01
Patel Sushil
Chief Executive Officer
2026-04-01
Xynos Konstantinos
Chief Medical Officer
2026-04-01
Schwendenman Andrew
Chief Accounting Officer
2026-04-01
Peeples-Dyer Veleka 2026-04-01
Sarchi Christopher
Chief Commercial Officer
2026-04-01